Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
6.01
+0.10 (1.78%)
Nov 28, 2025, 4:00 PM EST - Market closed
Predictive Oncology Revenue
Predictive Oncology had revenue of $3.62K in the quarter ending September 30, 2025, a decrease of -7.40%. This brings the company's revenue in the last twelve months to $1.66M, up 320.71% year-over-year. In the year 2024, Predictive Oncology had annual revenue of $1.62M, down -0.24%.
Revenue (ttm)
$1.66M
Revenue Growth
+320.71%
P/S Ratio
2.00
Revenue / Employee
$69,350
Employees
24
Market Cap
20.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.62M | -3.88K | -0.24% |
| Dec 31, 2023 | 1.63M | 122.24K | 8.12% |
| Dec 31, 2022 | 1.51M | 84.78K | 5.97% |
| Dec 31, 2021 | 1.42M | 168.41K | 13.45% |
| Dec 31, 2020 | 1.25M | -159.29K | -11.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
POAI News
- 11 days ago - Predictive Oncology Inc. (POAI) Q3 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha
- 13 days ago - Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy - GlobeNewsWire
- 6 weeks ago - Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy - GlobeNewsWire
- 7 weeks ago - Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy - GlobeNewsWire
- 2 months ago - Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens - GlobeNewsWire
- 2 months ago - Predictive Oncology Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients - GlobeNewsWire
- 3 months ago - PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - GlobeNewsWire